Works matching IS 08876924 AND DT 2005 AND VI 19 AND IP 2
Results: 37
Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 268, doi. 10.1038/sj.leu.2403539
- By:
- Publication type:
- Article
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Genetic heterogeneity in multiple myeloma.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 191, doi. 10.1038/sj.leu.2403555
- By:
- Publication type:
- Article
WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literature.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Hyperleukocytosis complicating lonafarnib treatment in patients with chronic myelomonocytic leukemia.
- Published in:
- 2005
- By:
- Publication type:
- clinical trial
Upregulation of asparagine synthetase and cell cycle arrest in t(12;21)-positive ALL.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Reply to‘Upregulation of asparagine synthetase and cell cycle arrest in t(12;21) positive ALL’by Stams et al.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Reply to Krejci et al.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Reply to Stams et al.
- Published in:
- 2005
- By:
- Publication type:
- Letter
A novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA library.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 279, doi. 10.1038/sj.leu.2403583
- By:
- Publication type:
- Article
Biclonal blast crisis with a mutated ABL catalytic domain in a Ph, del (9q)-positive CML patient responsive to imatinib: drug resistance should be monitored in all patients irrespective of response status.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 275, doi. 10.1038/sj.leu.2403586
- By:
- Publication type:
- Article
Acute lymphoblastic leukemia after tandem autologous stem cell transplantations for multiple myeloma.
- Published in:
- 2005
- By:
- Publication type:
- Letter
CTLA-4 overexpression in CD19+/CD5+cells correlates with the level of cell cycle regulators and disease progression in B-CLL patients.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Mutations in the BRAF and N-ras genes in childhood acute lymphoblastic leukaemia.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Evaluation of real-time quantitative PCR machines for the monitoring of fusion gene transcripts using the Europe against cancer protocol.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 260, doi. 10.1038/sj.leu.2403592
- By:
- Publication type:
- Article
Acadesine induces apoptosis in B cells from mantle cell lymphoma and splenic marginal zone lymphoma.
- Published in:
- 2005
- By:
- Publication type:
- Letter
e6-a2 BCR-ABL1 fusion in T-cell acute lymphoblastic leukemia.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Telomeres and telomerase in paediatric patients with T-cell acute lymphoblastic leukaemia (T-ALL).
- Published in:
- 2005
- By:
- Publication type:
- Letter
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 230, doi. 10.1038/sj.leu.2403597
- By:
- Publication type:
- Article
CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 176, doi. 10.1038/sj.leu.2403598
- By:
- Publication type:
- Article
Effects of topoisomerase 2 inhibitors on the MLL gene in children receiving chemotherapy: a prospective study.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia.
- Published in:
- 2005
- By:
- Publication type:
- Case Study
Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 223, doi. 10.1038/sj.leu.2403601
- By:
- Publication type:
- Article
New insight into the molecular mechanisms of MLL-associated leukemia.
- Published in:
- 2005
- By:
- Publication type:
- journal article
All common p210 and p190 Bcr-abl variants can be targeted by RNA interference.
- Published in:
- 2005
- By:
- Publication type:
- Letter
Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 245, doi. 10.1038/sj.leu.2403605
- By:
- Publication type:
- Article
High-mobility group A (HMGA) genes: from solid to liquid tumours?
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 195, doi. 10.1038/sj.leu.2403606
- By:
- Publication type:
- Article
Dose intensity and the toxicity and efficacy of allogeneic hematopoietic cell transplantation.
- Published in:
- 2005
- By:
- Publication type:
- research
Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Amplification or duplication of chromosome band 21q22 with multiple copies of the AML1 gene and mutation of the TP53 gene in therapy-related MDS and AML.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 197, doi. 10.1038/sj.leu.2403612
- By:
- Publication type:
- Article
Genetic polymorphism of NAD(P)H:quinone oxidoreductase is associated with an increased risk of infant acute lymphoblastic leukemia without MLL gene rearrangements.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Large granular lymphocyte (LGL)-like clonal expansions in paroxysmal nocturnal hemoglobinuria (PNH) patients.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 217, doi. 10.1038/sj.leu.2403617
- By:
- Publication type:
- Article
Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.
- Published in:
- Leukemia (08876924), 2005, v. 19, n. 2, p. 201, doi. 10.1038/sj.leu.2403619
- By:
- Publication type:
- Article
Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cells.
- Published in:
- 2005
- By:
- Publication type:
- Correction Notice